You are here

MEDIMMUNE, INC.

Company Information
Address
35 WEST WATKINS MILL RD
Gaithersburg, MD 20878
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. CAPSOMERES AS BASIS FOR A HUMAN PAPILLOMAVIRUS VACCINE

    Amount: $99,986.00

    N/A

    SBIRPhase I1998Department of Health and Human Services
  2. LYME VACCINE BASED ON BORRELIA DECORIN ADHESIN

    Amount: $750,000.00

    N/A

    SBIRPhase II1997Department of Health and Human Services
  3. ADHESIN BASED VACCINE TO PREVENT URINARY TRACT INFECTION

    Amount: $748,501.00

    N/A

    SBIRPhase II1997Department of Health and Human Services
  4. LYME VACCINE BASED ON BORRELIA DECORIN ADHESIN

    Amount: $98,937.00

    N/A

    SBIRPhase I1996Department of Health and Human Services
  5. ADHESIN BASED VACCINE TO PREVENT URINARY TRACT INFECTION

    Amount: $99,969.00

    N/A

    SBIRPhase I1996Department of Health and Human Services
  6. LYME VACCINE BASED ON BORRELIA TRANSFERIN RECEPTORS

    Amount: $99,931.00

    N/A

    SBIRPhase I1996Department of Health and Human Services
  7. CD4 Based Therapeutic Vaccine for HIV

    Amount: $99,983.00

    An effective therapeutic vaccine for HIV should be capable of reducing viral load and spread of infprevent the onset of AIDS. In an SIV-rhesus macaque model, immunization with a recombinant, solubleCD ...

    SBIRPhase I1995Department of Health and Human Services
  8. Lyme Disease Vaccine Using Gonococcal Blebs

    Amount: $100,000.00

    The investigators will develop a system in which OspA, an antigen known to induce protective immuneagainst Borrelia burgdorferi, the causative agent of Lyme Disease, is cloned and exported to the outN ...

    SBIRPhase I1995Department of Health and Human Services
  9. Monoclonal Antibodies to Respiratory Syncytial Virus

    Amount: $81,000.00

    Respiratory syncytial virus (RSv) is the primary etiologic agent of pediatric respiratory tractinfection. In premature infants and children with bronchopulmonary dysplasia or congenital heartdisease, ...

    SBIRPhase I1994Department of Health and Human Services
  10. HUMAN-MURINE CHIMERIC ANTIBODIES VS. RESPIRATORY SYNCYTIAL VIRUS

    Amount: $428,150.00

    RESPIRATORY SYNCYTIAL VIRUS (RSV) IS RESPONSIBLE FOR YEARLY EPIDEMICS OF BRONCHIOLITIS AND PNEUMONIA IN INFANTS AND YOUNG CHILDREN. AT RISK OF SERIOUS RSV MORBIDITY ARE CHILDREN WITH UNDERLYING DISEAS ...

    SBIRPhase II1993Department of Health and Human Services
US Flag An Official Website of the United States Government